ROMO1 and neoplasm: In hepatocellular carcinoma, colorectal cancer, and breast cancer, overexpression of ROMO1 has been associated with enhanced tumor cell proliferation, migration, and invasion, often linked to ROS-mediated activation of MAPK and NF-κB pathways [1,6,7].